NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN) SEC filings
NRSN SEC filings moved a median of -1.80% by the close. NRSN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NRSN overview →
128 measured NRSN SEC filing events.
Where these NRSN SEC filings landedvs 127 measured NRSN SEC filing reactions
| Middle 50% of NRSN SEC filing reactions | -5.22% to +1.54% |
|---|---|
| Median reaction (to close) | -1.80% |
| Measured reactions | 127 |
Point-in-time · zero look-ahead
Half of the 127 NRSN SEC filing events with a measured close landed between -5.22% and +1.54%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K NeuroSense Therapeutics For: Oct 13 | SEC filing · Form 6-K | +9.05% | +0.58% | |
| Form 6-K NeuroSense Therapeutics For: Oct 02 | SEC filing · Form 6-K | -2.46% | -0.74% | |
| Form 6-K NeuroSense Therapeutics For: Jun 30 | SEC filing · Form 6-K | +3.47% | -26.19% | |
| Form 6-K NeuroSense Therapeutics For: Sep 09 | SEC filing · Form 6-K | -1.45% | -12.63% | |
| Form 6-K NeuroSense Therapeutics For: Aug 27 | SEC filing · Form 6-K | -4.52% | -4.46% | |
| Form 6-K NeuroSense Therapeutics For: Aug 13 | SEC filing · Form 6-K | +0.00% | -2.12% | |
| Form 6-K NeuroSense Therapeutics For: Aug 06 | SEC filing · Form 6-K | -3.47% | -8.51% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +7.63% | +18.83% | |
| Form 6-K NeuroSense Therapeutics For: Jul 31 | SEC filing · Form 6-K | +7.63% | +18.83% | |
| Form F-3/A NeuroSense Therapeutics | SEC filing · Form F-3 | +1.23% | -3.08% | |
| Form 6-K NeuroSense Therapeutics For: Jul 22 | SEC filing · Form 6-K | +1.13% | -4.45% | |
| Form 6-K NeuroSense Therapeutics For: Jun 29 | SEC filing · Form 6-K | -9.05% | -18.45% | |
| Form 6-K NeuroSense Therapeutics For: Jun 25 | SEC filing · Form 6-K | -6.24% | -5.24% | |
| Form 6-K NeuroSense Therapeutics For: Jun 11 | SEC filing · Form 6-K | -1.65% | -0.14% | |
| Form 6-K NeuroSense Therapeutics For: Jun 09 | SEC filing · Form 6-K | — | -4.34% | |
| Form 6-K NeuroSense Therapeutics For: Jun 08 | SEC filing · Form 6-K | +0.00% | -2.40% | |
| Form 6-K NeuroSense Therapeutics For: Apr 28 | SEC filing · Form 6-K | +0.25% | -0.05% | |
| Form 6-K NeuroSense Therapeutics For: Apr 24 | SEC filing · Form 6-K | -1.22% | +2.89% | |
| Form 6-K NeuroSense Therapeutics For: Apr 06 | SEC filing · Form 6-K | +2.38% | -9.29% | |
| Form 6-K NeuroSense Therapeutics For: Apr 03 | SEC filing · Form 6-K | +2.38% | -9.29% | |
| Form 20-F NeuroSense Therapeutics For: Dec 31 | SEC filing · Form 20-F | -2.74% | +3.42% | |
| Form 6-K NeuroSense Therapeutics For: Mar 31 | SEC filing · Form 6-K | -2.74% | +3.42% | |
| Form 6-K NeuroSense Therapeutics For: Mar 24 | SEC filing · Form 6-K | -3.22% | -2.10% | |
| Form 6-K NeuroSense Therapeutics For: Mar 16 | SEC filing · Form 6-K | -4.35% | -0.22% | |
| Form 6-K NeuroSense Therapeutics For: Mar 11 | SEC filing · Form 6-K | -0.35% | +2.69% | |
| Form 6-K NeuroSense Therapeutics For: Feb 18 | SEC filing · Form 6-K | -6.71% | -18.75% | |
| Form 6-K NeuroSense Therapeutics For: Feb 13 | SEC filing · Form 6-K | -1.43% | -4.76% | |
| Form 6-K NeuroSense Therapeutics For: Feb 09 | SEC filing · Form 6-K | +1.09% | +12.09% | |
| Form F-3 NeuroSense Therapeutics | SEC filing · Form F-3 | +0.78% | -2.13% | |
| Form 6-K NeuroSense Therapeutics For: Jan 06 | SEC filing · Form 6-K | -3.00% | -5.19% | |
| Form 6-K NeuroSense Therapeutics For: Dec 22 | SEC filing · Form 6-K | +0.00% | -2.21% | |
| Form 6-K NeuroSense Therapeutics For: Dec 08 | SEC filing · Form 6-K | -0.93% | -7.48% | |
| Form 6-K NeuroSense Therapeutics For: Dec 04 | SEC filing · Form 6-K | -0.01% | -3.23% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | -2.88% | +12.50% | |
| Form 6-K NeuroSense Therapeutics For: Nov 24 | SEC filing · Form 6-K | +0.69% | +0.95% | |
| Form 6-K NeuroSense Therapeutics For: Nov 21 | SEC filing · Form 6-K | -0.47% | +2.80% | |
| Form F-3 NeuroSense Therapeutics | SEC filing · Form F-3 | +0.00% | -6.20% | |
| Form 6-K NeuroSense Therapeutics For: Oct 06 | SEC filing · Form 6-K | -1.40% | -6.40% | |
| Form 6-K NeuroSense Therapeutics For: Sep 25 | SEC filing · Form 6-K | +1.64% | -3.28% | |
| Form 6-K NeuroSense Therapeutics For: Sep 10 | SEC filing · Form 6-K | +15.12% | -9.93% | |
| Form 6-K NeuroSense Therapeutics For: Sep 04 | SEC filing · Form 6-K | -0.91% | +0.00% | |
| Form 6-K NeuroSense Therapeutics For: Sep 02 | SEC filing · Form 6-K | +1.79% | -0.95% | |
| Form 6-K NeuroSense Therapeutics For: Aug 21 | SEC filing · Form 6-K | +1.75% | +2.90% | |
| Form 6-K NeuroSense Therapeutics For: Aug 20 | SEC filing · Form 6-K | +10.76% | +1.47% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +0.00% | — | |
| Form POS AM NeuroSense Therapeutics | SEC filing · Form POS | +1.68% | +5.04% | |
| Form S-8 NeuroSense Therapeutics | SEC filing · Form S-8 | +1.68% | +5.04% | |
| Form 6-K NeuroSense Therapeutics For: Jun 30 | SEC filing · Form 6-K | -20.57% | -38.29% | |
| Form 6-K NeuroSense Therapeutics For: Jul 10 | SEC filing · Form 6-K | -1.84% | -2.77% | |
| Form 6-K NeuroSense Therapeutics For: Jun 26 | SEC filing · Form 6-K | -1.81% | -8.76% | |
| Form 6-K NeuroSense Therapeutics For: May 07 | SEC filing · Form 6-K | +0.00% | -2.14% | |
| Form 6-K NeuroSense Therapeutics For: Apr 24 | SEC filing · Form 6-K | -0.49% | -1.96% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +0.00% | -3.43% | |
| Form POS AM NeuroSense Therapeutics | SEC filing · Form POS | -7.33% | -0.92% | |
| Form 20-F NeuroSense Therapeutics For: Dec 31 | SEC filing · Form 20-F | -2.02% | -4.26% | |
| Form 6-K NeuroSense Therapeutics For: Apr 07 | SEC filing · Form 6-K | -2.02% | -4.26% | |
| Form 6-K NeuroSense Therapeutics For: Mar 27 | SEC filing · Form 6-K | -5.31% | -7.96% | |
| Form 6-K NeuroSense Therapeutics For: Mar 19 | SEC filing · Form 6-K | -4.31% | -7.68% | |
| Form 6-K NeuroSense Therapeutics For: Feb 19 | SEC filing · Form 6-K | -3.44% | -5.04% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | -1.79% | -2.68% | |
| Form 6-K NeuroSense Therapeutics For: Jan 06 | SEC filing · Form 6-K | — | -2.42% | |
| Form F-3 NeuroSense Therapeutics | SEC filing · Form F-3 | +1.83% | +4.07% | |
| Form 6-K NeuroSense Therapeutics For: Dec 23 | SEC filing · Form 6-K | -9.20% | +4.17% | |
| Form 6-K NeuroSense Therapeutics For: Dec 18 | SEC filing · Form 6-K | +0.00% | -3.39% | |
| Form 6-K NeuroSense Therapeutics For: Dec 17 | SEC filing · Form 6-K | +3.01% | +9.01% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | -4.59% | -7.53% | |
| Form D NeuroSense Therapeutics | SEC filing · Form D | -4.59% | -7.53% | |
| Form 6-K NeuroSense Therapeutics For: Dec 11 | SEC filing · Form 6-K | -3.09% | -6.17% | |
| Form F-3 NeuroSense Therapeutics | SEC filing · Form F-3 | -3.70% | -5.56% | |
| Form 6-K NeuroSense Therapeutics For: Dec 04 | SEC filing · Form 6-K | -0.87% | -6.96% | |
| Form 6-K NeuroSense Therapeutics For: Dec 02 | SEC filing · Form 6-K | +0.00% | +4.63% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +3.02% | -2.51% | |
| Form F-1 NeuroSense Therapeutics | SEC filing · Form F-1 | +0.00% | -10.80% | |
| Form 6-K NeuroSense Therapeutics For: Nov 12 | SEC filing · Form 6-K | — | +0.76% | |
| Form 6-K NeuroSense Therapeutics For: Oct 31 | SEC filing · Form 6-K | — | -0.79% | |
| Form 6-K NeuroSense Therapeutics For: Oct 30 | SEC filing · Form 6-K | — | -2.98% | |
| Form 6-K NeuroSense Therapeutics For: Oct 28 | SEC filing · Form 6-K | +1.54% | +3.85% | |
| Form 6-K NeuroSense Therapeutics For: Oct 24 | SEC filing · Form 6-K | -7.89% | +6.14% | |
| Form 6-K NeuroSense Therapeutics For: Oct 15 | SEC filing · Form 6-K | -0.85% | -18.90% | |
| Form 6-K NeuroSense Therapeutics For: Oct 09 | SEC filing · Form 6-K | -1.61% | -1.33% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +4.37% | +1.63% | |
| Form POS AM NeuroSense Therapeutics | SEC filing · Form POS | -3.20% | -2.40% | |
| Form 6-K NeuroSense Therapeutics For: Jun 30 | SEC filing · Form 6-K | -3.20% | -2.40% | |
| Form 6-K NeuroSense Therapeutics For: Sep 24 | SEC filing · Form 6-K | +0.00% | -0.79% | |
| Form 6-K NeuroSense Therapeutics For: Sep 16 | SEC filing · Form 6-K | +0.00% | +7.20% | |
| Form 6-K NeuroSense Therapeutics For: Sep 09 | SEC filing · Form 6-K | +6.42% | +15.81% | |
| Form 6-K NeuroSense Therapeutics For: Aug 30 | SEC filing · Form 6-K | -2.75% | +6.96% | |
| Form 6-K NeuroSense Therapeutics For: Aug 28 | SEC filing · Form 6-K | +3.33% | -1.66% | |
| Form 6-K NeuroSense Therapeutics For: Aug 26 | SEC filing · Form 6-K | -0.13% | +1.37% | |
| Form 6-K NeuroSense Therapeutics For: Aug 16 | SEC filing · Form 6-K | +0.00% | +2.13% | |
| Form 6-K NeuroSense Therapeutics For: Aug 07 | SEC filing · Form 6-K | -1.97% | -13.40% | |
| Form 6-K NeuroSense Therapeutics For: Aug 01 | SEC filing · Form 6-K | +3.08% | -14.46% | |
| Form 6-K NeuroSense Therapeutics For: Jul 09 | SEC filing · Form 6-K | +1.68% | -25.89% | |
| Form 6-K NeuroSense Therapeutics For: Jul 03 | SEC filing · Form 6-K | -0.75% | -1.49% | |
| Form 6-K NeuroSense Therapeutics For: Jul 01 | SEC filing · Form 6-K | -5.35% | -3.57% | |
| Form 6-K NeuroSense Therapeutics For: Jun 27 | SEC filing · Form 6-K | +0.58% | +17.92% | |
| Form 6-K NeuroSense Therapeutics For: Jun 24 | SEC filing · Form 6-K | +0.24% | +0.51% | |
| Form 6-K NeuroSense Therapeutics For: Jun 21 | SEC filing · Form 6-K | +0.24% | +0.51% | |
| Form 6-K NeuroSense Therapeutics For: Dec 31 | SEC filing · Form 6-K | -4.37% | -0.25% | |
| Form 6-K NeuroSense Therapeutics For: May 28 | SEC filing · Form 6-K | +2.71% | -1.80% | |
| Form 6-K NeuroSense Therapeutics For: May 23 | SEC filing · Form 6-K | +0.00% | -1.10% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +0.00% | -8.66% | |
| Form 6-K NeuroSense Therapeutics For: May 20 | SEC filing · Form 6-K | +4.69% | -1.56% | |
| Form F-1/A NeuroSense Therapeutics | SEC filing · Form F-1 | -0.77% | -3.08% | |
| Form 6-K NeuroSense Therapeutics For: May 14 | SEC filing · Form 6-K | +7.21% | +0.90% | |
| Form F-1 NeuroSense Therapeutics | SEC filing · Form F-1 | +0.00% | -2.54% | |
| Form 6-K NeuroSense Therapeutics For: May 07 | SEC filing · Form 6-K | -3.71% | -3.01% | |
| Form D NeuroSense Therapeutics | SEC filing · Form D | +0.00% | -0.81% | |
| Form 6-K NeuroSense Therapeutics For: Apr 12 | SEC filing · Form 6-K | +0.97% | -1.29% | |
| Form 6-K NeuroSense Therapeutics For: Apr 10 | SEC filing · Form 6-K | -0.32% | -0.60% | |
| Form 6-K NeuroSense Therapeutics For: Apr 09 | SEC filing · Form 6-K | -0.54% | -7.53% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | -0.54% | -7.53% | |
| Form 6-K NeuroSense Therapeutics For: Apr 05 | SEC filing · Form 6-K | +2.34% | -20.19% | |
| Form 20-F NeuroSense Therapeutics For: Dec 31 | SEC filing · Form 20-F | +2.34% | -20.19% | |
| Form POS AM NeuroSense Therapeutics | SEC filing · Form POS | +2.34% | -20.19% | |
| Form 6-K NeuroSense Therapeutics For: Feb 22 | SEC filing · Form 6-K | +1.96% | +1.61% | |
| Form 6-K NeuroSense Therapeutics For: Feb 07 | SEC filing · Form 6-K | +0.80% | +2.40% | |
| Form 6-K NeuroSense Therapeutics For: Jan 09 | SEC filing · Form 6-K | -1.89% | -1.67% | |
| Form 6-K NeuroSense Therapeutics For: Dec 27 | SEC filing · Form 6-K | -1.33% | +4.00% | |
| Form 6-K NeuroSense Therapeutics For: Dec 21 | SEC filing · Form 6-K | +0.00% | -0.40% | |
| Form 6-K NeuroSense Therapeutics For: Dec 14 | SEC filing · Form 6-K | -3.89% | +7.25% | |
| Form 6-K NeuroSense Therapeutics For: Dec 05 | SEC filing · Form 6-K | +11.55% | +8.65% | |
| Form EFFECT NeuroSense Therapeutics | SEC filing · Form EFFECT | +11.55% | +8.65% | |
| Form POS AM NeuroSense Therapeutics | SEC filing · Form POS | +1.44% | +7.19% | |
| Form 6-K NeuroSense Therapeutics For: Nov 28 | SEC filing · Form 6-K | -0.61% | -0.02% | |
| Form POS AM NeuroSense Therapeutics | SEC filing · Form POS | +0.00% | +0.17% | |
| Form 6-K NeuroSense Therapeutics For: Nov 13 | SEC filing · Form 6-K | +5.00% | -0.20% | |
| Form 6-K NeuroSense Therapeutics For: Nov 06 | SEC filing · Form 6-K | +5.29% | +9.61% |
Keep exploring
More NRSN: earnings → · analyst actions → · NRSN overview →